We are proud to be a woman-owned business that leads the world in the manufacturing of generic respiratory medications.
The FDA approved our first generic respiratory medication in 1997, and since then we've been committed to bringing safe, effective, and affordable medications to patients in need.
Our mission to improve patient outcomes has fueled our commitment to innovation, quality, and service.
We've invested in a state-of-the-art facility and industry-leading technology to expand our capacity to help patients.
We've opened an outsourcing division to help health care facilities that need 503B compounded drugs, often during drug shortages.
Our new facility also equips us to develop and bring new ophthalmic and injectable medications to market.